tiprankstipranks
Crispr Therapeutics AG (CRSP)
NASDAQ:CRSP

Crispr Therapeutics AG (CRSP) Technical Analysis

7,751 Followers

Technical Sentiment

Overall Consensus
Buy
14Bullish
2Neutral
6Bearish
Technical Analysis Consensus
Sell
3Bullish
2Neutral
5Bearish
Moving Average Consensus
Strong Buy
11Bullish
0Neutral
1Bearish
Crispr Therapeutics AG’s (CRSP) Moving Averages Convergence Divergence (MACD) indicator is 0.77, suggesting Crispr Therapeutics AG is a Sell.
Crispr Therapeutics AG’s (CRSP) 20-Day exponential moving average is 57.47, while Crispr Therapeutics AG’s (CRSP) share price is $62.31, making it a Buy.
Crispr Therapeutics AG’s (CRSP) 50-Day exponential moving average is 58.99, while Crispr Therapeutics AG’s (CRSP) share price is $62.31, making it a Buy.

Crispr Therapeutics AG (CRSP) Pivot Points

Jun 12, 2024, 09:00 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
54.55
55.68
57.83
58.96
61.11
62.24
64.39
Fibonacci
55.68
56.93
57.70
58.96
60.21
60.98
62.24
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Crispr Therapeutics AG (CRSP) Moving Averages

Jun 12, 2024, 09:00 AM
Period
Simple
Exponential
MA5
59.97Buy
59.94Buy
MA10
57.69Buy
58.56Buy
MA20
56.72Buy
57.47Buy
MA50
57.28Buy
58.99Buy
MA100
65.45Sell
61.19Buy
MA200
59.97Buy
58.42Buy
Crispr Therapeutics AG’s (CRSP) 10-Day exponential moving average is 58.56, while Crispr Therapeutics AG’s (CRSP) share price is $62.31, making it a Buy.
Crispr Therapeutics AG’s (CRSP) 100-Day exponential moving average is 61.19, while Crispr Therapeutics AG’s (CRSP) share price is $62.31, making it a Buy.
Crispr Therapeutics AG’s (CRSP) stock price is $62.31 and Crispr Therapeutics AG’s (CRSP) 50-day simple moving average is 57.28, creating a Buy signal.
Crispr Therapeutics AG’s (CRSP) stock price is $62.31 and Crispr Therapeutics AG’s (CRSP) 100-day simple moving average is 65.45, creating a Sell signal.
Crispr Therapeutics AG’s (CRSP) stock price is $62.31 and Crispr Therapeutics AG’s (CRSP) 200-day simple moving average is 59.97, creating a Buy signal.

Crispr Therapeutics AG (CRSP) Technical Indicators

Jun 12, 2024, 09:00 AM
Name
Value
Implied Action
RSI (14)
63.66
Neutral
STOCH (9,6)
84.87
Sell
STOCHRSI (14)
85.16
Sell
MACD (12,26)
0.77
Sell
ADX (14)
16.82
Buy
Williams %R
-10.18
Sell
CCI (14)
192.54
Sell
ATR (14)
2.82
-
Ultimate Oscillator
66.38
Neutral
ROC
13.79
Buy
Crispr Therapeutics AG’s (CRSP) Relative Strength Index (RSI) is 63.66, creating a Neutral signal.
Crispr Therapeutics AG’s (CRSP) Trend Strength Indicator (ADX) is 16.82, creating a Buy signal.
Crispr Therapeutics AG’s (CRSP) Commodity Channel Index (CCI) is 192.54, creating a Sell signal.
Crispr Therapeutics AG’s (CRSP) Price Rate of Change (ROC) is 13.79, creating a Buy signal.

FAQ

Is CRSP a Buy, Hold, or Sell?
Based on CRSP’s technical indicators, CRSP is a Buy.
    What is CRSP’s RSI (14)?
    CRSP’s RSI (14) is 63.66, which suggests CRSP is a Neutral.
      What is CRSP’s MACD?
      CRSP’s MACD is 0.77, which suggests CRSP is a Sell.
        What is CRSP’s 5-day moving average?
        CRSP’s 5-day moving average is 59.97, which suggests CRSP is a Buy.
          What is CRSP’s 20-day moving average?
          CRSP 20-day moving average is 56.72, which suggests CRSP is a Buy.
            What is CRSP’s 50-day moving average?
            CRSP’s 50-day moving average is 57.28, which suggests CRSP is a Buy.
              What is CRSP’s 200-day moving average?
              CRSP’s 200-day moving average is 59.97, which suggests CRSP is a Buy.
                What is CRSP’s Williams % R (14)?
                CRSP’s Williams % R (14) is -10.18, which suggests CRSP is a Sell.
                  What is CRSP’s CCI (14)?
                  CRSP’s CCI (14) is 192.54, which suggests CRSP is a Sell.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis